Benylin Paediatric syrup 100.0 ml #1
Manufacturer: Johnson & Johnson, South Africa
Composition: diphenhydramine 7.0 mg
What is the active ingredient in Benylin Paediatric syrup?
Diphenhydramine hydrochloride
What is the dosage form of Benylin Paediatric?
Syrup
What is the recommended dosage for children 6 to 12 years old?
Two 5 ml medicine measures (10 ml) every 3 hours, not exceeding four doses per day.
Is Benylin Paediatric recommended for children under 6 years old?
No, it is not recommended for children under 6 years old.
What is the pharmacological action of diphenhydramine hydrochloride?
It is an antihistaminic and, by its atropine-like action, relieves cough.
What are the common side effects of diphenhydramine hydrochloride?
The most common side effect is sedation, which can range from slight drowsiness to deep sleep. Other side effects include gastrointestinal disturbances, antimuscarinic effects, and central effects like hypotension, muscular weakness, tinnitus, euphoria, and headache.
What are the contraindications for using Benylin Paediatric?
Known hypersensitivity to any of the ingredients, use with monoamine oxidase inhibitors, acute asthmatic attacks, impaired hepatic or renal function.
What are the warnings and special precautions associated with Benylin Paediatric?
It may lead to drowsiness and impaired concentration, which may be aggravated by alcohol or other central nervous system depressant agents. Patients should be warned not to drive, operate dangerous machinery, or climb dangerous heights.
What are the known symptoms of overdosage and particulars of its treatment?
Overdosage may be fatal, especially in infants and children. Symptoms include CNS stimulation, deepening coma, and cardiorespiratory collapse. Treatment is symptomatic and supportive.
How is Benylin Paediatric presented?
Bottles containing 100 ml with a plastic measuring cup.
What are the storage instructions for Benylin Paediatric?
Keep container tightly closed and store in a cool place (at or below 25°C).
What interactions may occur with Benylin Paediatric?
The anticholinergic effects of atropine and tricyclic antidepressants may be enhanced. MAO inhibitors may enhance the anticholinergic effects. It may mask the warning symptoms of ototoxic medicines and affect the metabolism of other medicines in the liver. It may enhance the sedative effect of central nervous system depressants.
What is the registration number of Benylin Paediatric?
H/10.1/12
Who is the holder of the certificate of registration for Benylin Paediatric?
Johnson & Johnson (Pty) Ltd.
What is the date of publication of the package insert for Benylin Paediatric?
18 April 1987